AASLD-EASL HBV Endpoints 2022
03 JUNE 2022 – 04 JUNE 2022 | HEPATOLOGY
The American Association for Study of Liver Diseases (AASLD) and European Association for Study of the Liver (EASL) will meet to collaborate at HBV Endpoints in Washington, D.C, USA later this year, with a focus on viral hepatitis. The purpose of this congress is to bring together academics, practising physicians, pharmaceutical companies, and patients to discuss therapeutic endpoints and novel approaches to chronic hepatitis B and D.
FIND OUT MORE>>
22 JUNE 2022 – 26 JUNE 2022 | HEPATOLOGY
International Liver Congress™ is EASL’s flagship event, attracting thousands of scientific and medical experts from around the world to learn about the latest in liver research and to exchange clinical experiences. Delegates will present and share their work, and debate and draw conclusions on recent developments in science and research in hepatology, working to enhance the treatment and management of liver disease in clinical practice.
This premier event on the hepatology calendar is running for the 57th time in 2022. At ILC 2022, EASL brings this all back to you, safely, with a new model, reshaping the scientific programme, merging the very best of ILC tradition and cutting-edge developments. ILC 2022 will build on decades of ILC tradition, improving it with emerging insights.
Optimize Sepsis Testing with Culture-Independent Diagnostics
ON-DEMAND | MICROBIOLOGY & INFECTIOUS DISEASES
This exciting, on-demand webinar provides listeners with the latest information on the developing field of sepsis testing, and the impact of these new technologies on healthcare systems. Also giving an overview of current management of the condition, experts will present useful a framework tool which allows effective tailoring of diagnosis and treatment, and subsequently improved patient outcomes.